B40.0

Clinical Causes: Inhalation of airborne spores of Blastomyces dermatitidis, which are present in contaminated soil and decaying organic material. Activities involving soil disturbance, such as farming, construction, or excavation, which release spores into the air. Geographic exposure, particularly in central and southeastern United States, including parts of Ohio, Mississippi, and the Great Lakes region. Potential exposure in wilderness or forested areas with rich organic debris.

Key Symptoms: Fever that develops gradually or suddenly Cough, which may be dry or productive with sputum Shortness of breath or difficulty breathing Chest pain, especially sharp or persistent pain during respiration Fatigue and malaise Muscle and joint aches Night sweats Unintentional weight loss In some cases, symptoms may resemble bacterial pneumonia or other respiratory illnesses

Diagnosis Path: Microscopic examination of respiratory secretions or tissue samples to identify Blastomyces dermatitidis fungi Culturing specimens from sputum, tissue biopsies, or other samples to grow the organism Serological tests that detect antibodies or antigens specific to Blastomyces Molecular diagnostics such as PCR assays to detect fungal DNA

Treatment Protocols: Oral antifungals such as itraconazole for mild to moderate cases Amphotericin B, administered intravenously, for severe cases or when complications arise Prolonged therapy, often lasting several months, to ensure complete eradication Supportive care, including oxygen therapy and symptomatic management, as needed Monitoring for drug side effects and treatment response through regular follow-up assessments